References

1. Weaver JC, Chizmadzhev YA (1996) Theory of electroporation: A review. Bioelectrochemistry and Bioenergetics 41: 135-160. [CrossRef] [Google Scholar]
2. Jiang CL, Davalos RV, Bischof JC (2015) A Review of Basic to Clinical Studies of Irreversible Electroporation Therapy. IEEE Trans Biomed Eng 62: 4-20. [CrossRef] [Google Scholar] [PubMed]
3. Weaver JC, Harrison GI, Bliss JG, Mourant JR, Powell KT, et al. (1988) Electroporation: high frequency of occurrence of a transient high-permeability state in erythrocytes and intact yeast. FEBS Lett 229: 30-34. [CrossRef] [Google Scholar] [PubMed]
4. Neumann E, Rosenheck K (1972) Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol 10: 279-290. [CrossRef] [Google Scholar] [PubMed]
5. Zimmermann U, Pilwat G, Riemann F (1975) Preparation of erythrocyte ghosts by dielectric breakdown of the cell membrane. Biochim Biophys Acta 375: 209-219. [CrossRef] [Google Scholar] [PubMed]
6. Sale AJ, Hamilton WA (1968) Effects of high electric fields on micro-organisms. 3. Lysis of erythrocytes and protoplasts. Biochim Biophys Acta 163: 37-43. [CrossRef] [Google Scholar] [PubMed]
7. SUN Cai-xin, YAO Chen-guo, XIONG Lan (2002) Killing effects of pulsed electric fields on malignant tumor cell. Acta Biophysica Sinica 18: 474-477.
8. Lee EW, Wong D, Tafti BA, Prieto V, Totonchy M, et al. (2012) Irreversible electroporation in eradication of rabbit VX2 liver tumor. J Vasc Interv Radiol 23: 833-840. [CrossRef] [Google Scholar] [PubMed]
9. Garcia PA, Rossmeisl JH, Robertson J, Ellis TL, Davalos RV, et al. (2009) Pilot study of irreversible electroporation for intracranial surgery. Conf Proc IEEE Eng Med Biol Soc 2009: 6513-6516. [CrossRef] [Google Scholar] [PubMed]
10. Ellis TL, Garcia PA, Rossmeisl JH, Henao-Guerrero N, Robertson J, et al. (2011) Nonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation. J Neurosurg 114: 681-688. [CrossRef] [Google Scholar] [PubMed]
11. Garcia PA, Pancotto T, Rossmeisl JH, Henao-Guerrero N, Gustafson NR, et al. (2011) Non-thermal irreversible electroporation (N-TIRE) and adjuvant fractionated radiotherapeutic multimodal therapy for intracranial malignant glioma in a canine patient. Technol Cancer Res Treat 10: 73-83. [CrossRef] [Google Scholar] [PubMed]
12. Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, et al. (2010) Irreversible electroporation of the pancreas in swine: a pilot study. HPB 12: 348-351. [CrossRef] [Google Scholar] [PubMed]
13. Ueshima E, Schattner M, Mendelsohn R, Gerdes H, Monette S, et al. (2018) Transmural ablation of the normal porcine common bile duct with catheter-directed irreversible electroporation is feasible and does not affect duct patency. Gastrointest Endosc 87: 300 e1-300 e6. [CrossRef] [Google Scholar] [PubMed]
14. Luo X, Liang X, Li J, Shi J, Zhang W, et al. (2016) The Effects of Irreversible Electroporation on the Colon in a Porcine Model. PLoS One 11: e0167275. [CrossRef] [Google Scholar] [PubMed]
15. Fritz S, Sommer CM, Longerich T, Kuhn-Neureuther C, Radeleff B, et al. (2017) Successful ablation of lymph nodes using irreversible electroporation (IRE) in a porcine survival model. Langenbeck Arch Surg 402: 465-473. [CrossRef] [Google Scholar] [PubMed]
16. Rombouts SJ, Nijkamp MW, Van Dijck WP, Brosens LA, Konings M, et al. (2017) Irreversible Electroporation of the Pancreas Using Parallel Plate Electrodes in a Porcine Model: A Feasibility Study. PLoS One 12: e0169396. [CrossRef] [Google Scholar] [PubMed]
17. Rombouts SJE, Van Dijck WPM, Nijkamp MW, Derksen TC, Brosens LaA, et al. (2017) Clinical and pathological outcomes after irreversible electroporation of the pancreas using two parallel plate electrodes: a porcine model. HPB 19: 1058-1065. [CrossRef] [Google Scholar] [PubMed]
18. Fritz S, Sommer CM, Vollherbst D, Wachter MF, Longerich T, et al. (2015) Irreversible Electroporation of the Pancreas Is Feasible and Safe in a Porcine Survival Model. Pancreas 44: 791-798. [CrossRef] [Google Scholar] [PubMed]
19. Li J, Zeng J, Chen J, Shi J, Luo X, et al. (2017) Evaluation of the safety of irreversible electroporation on the stomach wall using a pig model. Exp Ther Med 14: 696-702. [CrossRef] [Google Scholar] [PubMed]
20. Tam AL, Figueira TA, Gagea M, Ensor JE, Dixon K, et al. (2016) Irreversible Electroporation in the Epidural Space of the Porcine Spine: Effects on Adjacent Structures. Radiology 281: 763-771. [CrossRef] [Google Scholar] [PubMed]
21. Chung DJ, Sung K, Osuagwu FC, Wu HH, Lassman C, et al. (2016) Contrast Enhancement Patterns after Irreversible Electroporation: Experimental Study of CT Perfusion Correlated to Histopathology in Normal Porcine Liver. J Vasc Interv Radiol 27: 104-111. [CrossRef] [Google Scholar] [PubMed]
22. Srimathveeravalli G, Silk M, Wimmer T, Monette S, Kimm S, et al. (2015) Feasibility of Catheter-Directed Intraluminal Irreversible Electroporation of Porcine Ureter and Acute Outcomes in Response to Increasing Energy Delivery. J Vasc Interv Radiol 26: 1059-1066. [CrossRef] [Google Scholar] [PubMed]
23. Tam AL, Abdelsalam ME, Gagea M, Ensor JE, Moussa M, et al. (2014) Irreversible Electroporation of the Lumbar Vertebrae in a Porcine Model: Is There Clinical-Pathologic Evidence of Neural Toxicity? Radiology 272: 709-719. [CrossRef] [Google Scholar] [PubMed]
24. Guo Y, Zhang Y, Klein R, Nijm GM, Sahakian AV, et al. (2010) Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res 70: 1555-1563. [CrossRef] [Google Scholar] [PubMed]
25. Jose A, Sobrevals L, Ivorra A, Fillat C (2012) Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models. Cancer Lett 317: 16-23. [CrossRef] [Google Scholar] [PubMed]
26. Sanchez-Velazquez P, Castellvi Q, Villanueva A, Iglesias M, Quesada R, et al. (2017) Long-term effectiveness of irreversible electroporation in a murine model of colorectal liver metastasis. Sci Rep 7: 44821. [CrossRef] [Google Scholar] [PubMed]
27. Edelblute CM, Hornef J, Burcus NI, Norman T, Beebe SJ, et al. (2017) Controllable Moderate Heating Enhances the Therapeutic Efficacy of Irreversible Electroporation for Pancreatic Cancer. Sci Rep 7: 11767. [Google Scholar]
28. Tartaglia E, Fabozzi M, Rizzuto A, Settembre A, Abete R, et al. (2018) Irreversible electroporation for locally advanced pancreatic cancer through a minimally invasive surgery supported by laparoscopic ultrasound. Int J Surg Case Rep 42: 290-294. [CrossRef] [Google Scholar] [PubMed]
29. Martin RC, Mcfarland K, Ellis S, Velanovich V (2012) Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. J Am Coll Surg 215: 361-369. [CrossRef] [Google Scholar] [PubMed]
30. Tian G, Liu X, Zhao Q, Xu D, Jiang T, et al. (2018) Irreversible Electroporation in Patients with Pancreatic Cancer: How Important Is the New Weapon? Biomed Res Int 2018: 5193067. [CrossRef] [Google Scholar] [PubMed]
31. Martin RCG, Kwon D, Chalikonda S, Sellers M, Kotz E, et al. (2015) Treatment of 200 Locally Advanced (Stage III) Pancreatic Adenocarcinoma Patients With Irreversible Electroporation Safety and Efficacy. Ann Surg 262: 486-494. [CrossRef] [Google Scholar] [PubMed]
32. Martin RC, Mcfarland K, Ellis S, Velanovich V (2013) Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol 3: 443-449. [CrossRef] [Google Scholar] [PubMed]
33. Belfiore G, Belfiore MP, Reginelli A, Capasso R, Romano F, et al. (2017) Concurrent chemotherapy alone versus irreversible electroporation followed by chemotherapy on survival in patients with locally advanced pancreatic cancer. Med Oncol 34: ARTN 3810.1007/s12032-017-0887-4. [CrossRef] [Google Scholar] [PubMed]
34. Lin M, Alnaggar M, Liang S, Wang X, Liang Y, et al. (2017) An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer. Oncotarget 8: 101795-101807. [CrossRef] [Google Scholar] [PubMed]
35. Ansari D, Kristoffersson S, Andersson R, Bergenfeldt M (2017) The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy. Scand J Gastroentero 52: 1165-1171. [CrossRef] [Google Scholar] [PubMed]
36. Huang KW, Yang PC, Pua U, Kim MD, Li SP, et al. (2018) The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma. J Surg Oncol 118: 31-36. [CrossRef] [Google Scholar] [PubMed]
37. Rashid MF, Hecht EM, Steinman JA, Kluger MD (2018) Irreversible electroporation of pancreatic adenocarcinoma: a primer for the radiologist. Abdom Radiol 43: 457-466. [CrossRef] [Google Scholar] [PubMed]
38. Papoulas M, Abdul-Hamid S, Peddu P, Cotoi C, Heaton N, et al. (2018) Irreversible electroporation in borderline resectable pancreatic adenocarcinoma for margin accentuation. J Surg Case Rep 2018: 127. [CrossRef] [Google Scholar] [PubMed]
39. Vroomen L, Scheffer HJ, Melenhorst M, De Jong MC, Van Den Bergh JE, et al. (2017) MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation. Eur Radiol 27: 2521-2531. [CrossRef] [Google Scholar] [PubMed]
40. Marsanic P, Mellano A, Sottile A, De Simone M (2017) Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma. Med Biol Eng Comput 55: 1123-1127. [CrossRef] [Google Scholar] [PubMed]
41. Vogel JA, Rombouts SJ, De Rooij T, Van Delden OM, Dijkgraaf MG, et al. (2017) Induction Chemotherapy Followed by Resection or Irreversible Electroporation in Locally Advanced Pancreatic Cancer (IMPALA): A Prospective Cohort Study. Ann Surg Oncol 24: 2734-2743. [CrossRef] [Google Scholar] [PubMed]
42. Orcutt S, Kis B, Malafa M (2017) Case report: Irreversible electroporation for locally advanced pancreatic cancer. Int J Surg Case Rep 40: 54-57. [CrossRef] [Google Scholar] [PubMed]
43. Ekici Y, Tezcaner T, Aydin HO, Boyvat F, Moray G, et al. (2016) Arterial complication of irreversible electroporation procedure for locally advanced pancreatic cancer. World J Gastrointest Oncol 8: 751-756. [CrossRef] [Google Scholar] [PubMed]
44. Yan L, Chen YL, Su M, Liu T, Xu K, et al. (2016) A Single-institution Experience with Open Irreversible Electroporation for Locally Advanced Pancreatic Carcinoma. Chinese Med J 129: 2920-2925. [CrossRef] [Google Scholar] [PubMed]
45. Paiella S, Butturini G, Frigerio I, Salvia R, Armatura G, et al. (2015) Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study. Digest Surg 32: 90-97. [CrossRef] [Google Scholar] [PubMed]
46. Weiss MJ, Wolfgang CL (2014) Irreversible electroporation: a novel therapy for stage III pancreatic cancer. Adv Surg 48: 253-258. [CrossRef] [Google Scholar] [PubMed]
47. Cohen EI, Field D, Lynskey GE, Kim AY (2018) Technology of irreversible electroporation and review of its clinical data on liver cancers. Expert Rev Med Devic 15: 99-106. [CrossRef] [Google Scholar] [PubMed]
48. Donadon M, Solbiati L, Dawson L, Barry A, Sapisochin G, et al. (2016) Hepatocellular Carcinoma: The Role of Interventional Oncology. Liver Cancer 6: 34-43. [CrossRef] [Google Scholar] [PubMed]
49. Li D, Kang J, Golas BJ, Yeung VW, Madoff DC, et al. (2014) Minimally invasive local therapies for liver cancer. Cancer Biol Med 11: 217-236. [CrossRef] [Google Scholar] [PubMed]
50. Granata V, Di Castelguidone ED, Fusco R, Catalano O, Piccirillo M, et al. (2016) Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area. Radiol Med 121: 122-131. [CrossRef] [Google Scholar] [PubMed]
51. Langan RC, Goldman DA, D'angelica MI, Dematteo RP, Allen PJ, et al. (2017) Recurrence patterns following irreversible electroporation for hepatic malignancies. J Surg Oncol 115: 704-710. [CrossRef] [Google Scholar] [PubMed]
52. Kingham TP, Karkar AM, D'angelica MI, Allen PJ, Dematteo RP, et al. (2012) Ablation of perivascular hepatic malignant tumors with irreversible electroporation. J Am Coll Surg 215: 379-987. [CrossRef] [Google Scholar] [PubMed]
53. Cheung W, Kavnoudias H, Roberts S, Szkandera B, Kemp W, et al. (2013) Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes. Technol Cancer Res Treat 12: 233-241. [CrossRef] [Google Scholar] [PubMed]
54. Niessen C, Jung EM, Wohlgemuth WA, Trabold B, Haimerl M, et al. (2013) Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft. Korean J Radiol 14: 797-800. [CrossRef] [Google Scholar] [PubMed]
55. Cheng RG, Bhattacharya R, Yeh MM, Padia SA (2015) Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis. J Vasc Interv Radiol 26: 1184-1188. [CrossRef] [Google Scholar] [PubMed]
56. Coelen RJS, Vogel JA, Vroomen L, Roos E, Busch ORC, et al. (2017) Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma (ALPACA): a multicentre phase I/II feasibility study protocol. BMJ Open 7: e015810. [CrossRef] [Google Scholar] [PubMed]
57. Herwald SE, Chen JH, Arellano RS (2016) Irreversible Electroporation for Treatment of Hepatocellular Carcinoma Adjacent to the Gallbladder. J Vasc Interv Radiol 27: 1093-1094. [CrossRef] [Google Scholar] [PubMed]
58. Eller A, Schmid A, Schmidt J, May M, Brand M, et al. (2015) Local Control of Perivascular Malignant Liver Lesions Using Percutaneous Irreversible Electroporation: Initial Experiences. Cardiovasc Inter Rad 38: 152-159. [CrossRef] [Google Scholar] [PubMed]
59. Martin RC, Schwartz E, Adams J, Farah I, Derhake BM, et al. (2015) Intra - operative Anesthesia Management in Patients Undergoing Surgical Irreversible Electroporation of the Pancreas, Liver, Kidney, and Retroperitoneal Tumors. Anesth Pain Med 5: e22786. [CrossRef] [Google Scholar] [PubMed]
60. Kos B, Voigt P, Miklavcic D, Moche M (2015) Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE). Radiol Oncol 49: 234-241. [CrossRef] [Google Scholar] [PubMed]
61. Dong S, Wang H, Zhao Y, Sun Y, Yao C, et al. (2018) First Human Trial of High-Frequency Irreversible Electroporation Therapy for Prostate Cancer. Technol Cancer Res Treat 17: 1533033818789692. [CrossRef] [Google Scholar] [PubMed]
62. Scheltema MJ, Chang JI, Van Den Bos W, Gielchinsky I, Nguyen TV, et al. (2018) Impact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segments. Diagn Interv Radiol 24: 268-275. [CrossRef] [Google Scholar] [PubMed]
63. Murray KS, Ehdaie B, Musser J, Mashni J, Srimathveeravalli G, et al. (2016) Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer. J Urology 196: 883-889. [CrossRef] [Google Scholar] [PubMed]
64. Van Den Bos W, Jurhill RR, De Bruin DM, Savci-Heijink CD, Postema AW, et al. (2016) Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study. J Urol 196: 552-559. [CrossRef] [Google Scholar] [PubMed]
65. Wendler JJ, Ganzer R, Hadaschik B, Blana A, Henkel T, et al. (2017) Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage. World J Urol 35: 11-20. [CrossRef] [Google Scholar] [PubMed]
66. Wendler JJ, Klink F, Seifert S, Fischbach F, Jandrig B, et al. (2016) Irreversible Electroporation of Prostate Cancer: Patient-Specific Pretreatment Simulation by Electric Field Measurement in a 3D Bioprinted Textured Prostate Cancer Model to Achieve Optimal Electroporation Parameters for Image-Guided Focal Ablation. Cardiovasc Inter Rad 39: 1668-1671. [CrossRef] [Google Scholar] [PubMed]
67. Van Den Bos W, De Bruin DM, Jurhill RR, Savci-Heijink CD, Muller BG, et al. (2016) The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients. World J Urol 34: 657-664. [CrossRef] [Google Scholar] [PubMed]
68. Scheltema MJ, Chang JI, Van Den Bos W, Gielchinsky I, Nguyen TV, et al. (2018) Impact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segments. Diagn Interv Radiol 24: 268-275. [CrossRef] [Google Scholar] [PubMed]
69. Van Den Bos W, Scheltema MJ, Siriwardana AR, Kalsbeek AMF, Thompson JE, et al. (2018) Focal irreversible electroporation as primary treatment for localized prostate cancer. Bju Int 121: 716-724. [CrossRef] [Google Scholar] [PubMed]
70. Scheltema MJ, Van Den Bos W, De Bruin DM, Wijkstra H, Laguna MP, et al. (2016) Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial. BMC Cancer 16: 299. [CrossRef] [Google Scholar] [PubMed]
71. Fitzal F, Mittlboeck M, Trischler H, Krois W, Nehrer G, et al. (2008) Breast-conserving therapy for centrally located breast cancer. Ann Surg 247: 470-476. [CrossRef] [Google Scholar] [PubMed]
72. Neal RE, Singh R, Hatcher HC, Kock ND, Torti SV, et al. (2010) Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode. Breast Cancer Res Treat 123: 295-301. [CrossRef] [Google Scholar] [PubMed]
73. Neal RE, Davalos RV (2009) The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems. Ann Biomed Eng 37: 2615-2625. [CrossRef] [Google Scholar] [PubMed]
74. Goswami I, Coutermarsh-Ott S, Morrison RG, Allen IC, Davalos RV, et al. (2017) Irreversible electroporation inhibits pro-cancer inflammatory signaling in triple negative breast cancer cells. Bioelectrochemistry 113: 42-50. [CrossRef] [Google Scholar] [PubMed]
75. Baur ADJ, Collettini F, Enders J, Maxeiner A, Schreiter V, et al. (2017) MRI-TRUS fusion for electrode positioning during irreversible electroporation for treatment of prostate cancer. Diagn Interv Radiol 23: 321-325. [CrossRef] [Google Scholar] [PubMed]
76. Bhutiani N, Philips P, Scoggins CR, Mcmasters KM, Potts MH, et al. (2016) Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC). HPB 18: 593-599. [CrossRef] [Google Scholar] [PubMed]
77. Niessen C, Igl J, Pregler B, Beyer L, Noeva E, et al. (2015) Factors Associated with Short-Term Local Recurrence of Liver Cancer after Percutaneous Ablation Using Irreversible Electroporation: A Prospective Single-Center Study. J Vasc Interv Radiol 26: 694-702. [CrossRef] [Google Scholar] [PubMed]
78. Golberg A, Bruinsma BG, Uygun BE, Yarmush ML (2015) Tissue heterogeneity in structure and conductivity contribute to cell survival during irreversible electroporation ablation by "electric field sinks''. Sci Rep-Uk. [Google Scholar]
79. Au JT, Wong J, Mittra A, Carpenter S, Haddad D, et al. (2011) Irreversible electroporation is a surgical ablation technique that enhances gene transfer. Surgery 150: 474-479. [CrossRef] [Google Scholar] [PubMed]
80. Yang Y, Qin Z, Du D, Wu Y, Qiu S, et al. (2018) Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Liver Cancer. Cardiovasc Intervent Radiol 42: 48-59. [CrossRef] [Google Scholar] [PubMed]
81. Sano MB, Fan RE, Cheng K, Saenz Y, Sonn GA, et al. (2018) Reduction of Muscle Contractions during Irreversible Electroporation Therapy Using High-Frequency Bursts of Alternating Polarity Pulses: A Laboratory Investigation in an Ex Vivo Swine Model. J Vasc Interv Radiol 29: 893-898. [CrossRef] [Google Scholar] [PubMed]